Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Invested Capital (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Invested Capital data on record, last reported at $243.5 million in Q4 2025.

  • For Q4 2025, Invested Capital fell 60.81% year-over-year to $243.5 million; the TTM value through Dec 2025 reached $243.5 million, down 60.81%, while the annual FY2025 figure was $243.5 million, 60.81% down from the prior year.
  • Invested Capital reached $243.5 million in Q4 2025 per MRVI's latest filing, down from $538.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.4 billion in Q4 2022 and bottomed at $243.5 million in Q4 2025.
  • Average Invested Capital over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Invested Capital: skyrocketed 58.44% in 2022, then tumbled 60.81% in 2025.
  • A 5-year view of Invested Capital shows it stood at $1.1 billion in 2021, then soared by 33.15% to $1.4 billion in 2022, then decreased by 8.28% to $1.3 billion in 2023, then crashed by 52.72% to $621.2 million in 2024, then crashed by 60.81% to $243.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $243.5 million in Q4 2025, $538.3 million in Q3 2025, and $761.9 million in Q2 2025.